Front Row Advisors’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.67K | Buy |
221
+61
| +38% | +$2.39K | ﹤0.01% | 386 |
|
2025
Q1 | $6.26K | Hold |
160
| – | – | ﹤0.01% | 401 |
|
2024
Q4 | $5.41K | Hold |
160
| – | – | ﹤0.01% | 402 |
|
2024
Q3 | $6.6K | Sell |
160
-200
| -56% | -$8.26K | ﹤0.01% | 392 |
|
2024
Q2 | $14K | Hold |
360
| – | – | ﹤0.01% | 496 |
|
2024
Q1 | $15.5K | Buy |
360
+200
| +125% | +$8.61K | 0.01% | 475 |
|
2023
Q4 | $5.99K | Hold |
160
| – | – | ﹤0.01% | 364 |
|
2023
Q3 | $5.86K | Hold |
160
| – | – | ﹤0.01% | 635 |
|
2023
Q2 | $6K | Hold |
160
| – | – | ﹤0.01% | 632 |
|
2023
Q1 | $6K | Hold |
160
| – | – | ﹤0.01% | 635 |
|
2022
Q4 | $6K | Hold |
160
| – | – | ﹤0.01% | 606 |
|
2022
Q3 | $5K | Sell |
160
-260
| -62% | -$8.13K | ﹤0.01% | 650 |
|
2022
Q2 | $23K | Sell |
420
-7
| -2% | -$383 | 0.01% | 357 |
|
2022
Q1 | $24K | Sell |
427
-13
| -3% | -$731 | 0.01% | 373 |
|
2021
Q4 | $25K | Hold |
440
| – | – | 0.01% | 380 |
|
2021
Q3 | $21K | Hold |
440
| – | – | 0.01% | 407 |
|
2021
Q2 | $23K | Buy |
440
+280
| +175% | +$14.6K | 0.01% | 392 |
|
2021
Q1 | $7K | Sell |
160
-166
| -51% | -$7.26K | ﹤0.01% | 635 |
|
2020
Q4 | $15K | Sell |
326
-6
| -2% | -$276 | 0.01% | 432 |
|
2020
Q3 | $15K | Buy |
332
+78
| +31% | +$3.52K | 0.01% | 424 |
|
2020
Q2 | $13K | Hold |
254
| – | – | 0.01% | 416 |
|
2020
Q1 | $13K | Buy |
254
+140
| +123% | +$7.17K | 0.01% | 409 |
|
2019
Q4 | $7K | Buy |
+114
| New | +$7K | ﹤0.01% | 541 |
|
2019
Q2 | – | Sell |
-48
| Closed | -$3K | – | 1051 |
|
2019
Q1 | $3K | Hold |
48
| – | – | ﹤0.01% | 732 |
|
2018
Q4 | $2K | Hold |
48
| – | – | ﹤0.01% | 783 |
|
2018
Q3 | $2 | Sell |
48
-157
| -77% | -$7 | ﹤0.01% | 788 |
|
2018
Q2 | $11 | Sell |
205
-1
| -0.5% | – | 0.01% | 435 |
|
2018
Q1 | $10K | Sell |
206
-3
| -1% | -$146 | 0.01% | 435 |
|
2017
Q4 | $9K | Buy |
+209
| New | +$9K | 0.01% | 446 |
|